000 01665 a2200421 4500
005 20250514034319.0
264 0 _c20021224
008 200212s 0 0 eng d
022 _a0169-5002
024 7 _a10.1016/s0169-5002(01)00493-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGrigorescu, Alexandru C
245 0 0 _aGemcitabine (GEM) and carboplatin (CBDCA) versus cisplatin (CDDP) and vinblastine (VLB) in advanced non-small-cell lung cancer (NSCLC) stages III and IV: a phase III randomised trial.
_h[electronic resource]
260 _bLung cancer (Amsterdam, Netherlands)
_cJul 2002
300 _a9-14 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
650 0 4 _aAged
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aCarboplatin
_xadministration & dosage
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xdrug therapy
650 0 4 _aCisplatin
_xadministration & dosage
650 0 4 _aDeoxycytidine
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aSurvival
650 0 4 _aTreatment Outcome
650 0 4 _aVinblastine
_xadministration & dosage
650 0 4 _aGemcitabine
700 1 _aDraghici, Ioana N
700 1 _aNitipir, Cornelia
700 1 _aGutulescu, Nicolae
700 1 _aCorlan, Emil
773 0 _tLung cancer (Amsterdam, Netherlands)
_gvol. 37
_gno. 1
_gp. 9-14
856 4 0 _uhttps://doi.org/10.1016/s0169-5002(01)00493-7
_zAvailable from publisher's website
999 _c11953516
_d11953516